Canadian Population Serological Survey Utilizing Antenatal Serum Samples

Overview

Acronym
CPSS_Antenatal
Website
CPSS_Antenatal
Investigators
  • Dr. Deborah Money

    University of British Columbia

Contacts
  • Janice Andrade

    University of British Columbia

General Design

Study design
Cross-sectional
Start Year
2020
End Year
2021
General Information on Follow Up (profile, frequency)
Periodic assessment of seroprevalence of SARS-CoV-2 utilizing clinically collected prenatal serology samples may be planned for future time points. The frequency and number of samples will be determined based on findings from the first cross-sectional assessment.
Recruitment Target
  • Individuals
Number of Participants
18,000
Supplementary information about number of participants
Cohort 1: 18,000 participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Timeline

Populations

CPSS_Antenatal - Cohort 1

Selection Criteria

Gender
Women only
Pregnant Women
  • First trimester
Countries
  • Canada
Territory
British Columbia, Yukon, Alberta, Northwest Territories, Saskatchewan, Manitoba, Ontario, Quebec, Newfoundland, New Brunswick, Nova Scotia, Prince Edward Island, Nunavut
Other Criteria
Had a routine blood screening of the antibody status to rubella, HIV, Hepatits B and syphilis

Sources of Recruitment

Specific Population
  • Clinic patients
Supplementary Information
Pregnant women who get a routine blood screening for prenatal care and who have their serological test results available for testing.

Sample Size

Number of Participants
18,000
Number of Participants with Biological Samples
18,000

Data Collection Events

# Name Description Start End
0 CPSS_Antenatal - Cohort 1 - Serotest 2020 (November) 2021 (March)
CPSS_Antenatal - Cohort 2

Selection Criteria

Gender
Women only
Pregnant Women
  • First trimester
  • Second trimester
Countries
  • Canada
Territory
British Columbia, Yukon, Alberta, Northwest Territories, Saskatchewan, Manitoba, Ontario, Quebec, Newfoundland, New Brunswick, Nova Scotia, Prince Edward Island, Nunavut
Other Criteria
Had an aneuploidy blood screening

Sources of Recruitment

Specific Population
  • Clinic patients
Supplementary Information
Pregnant women who get a routine blood screening for prenatal care and who have their aneuploidy test results data available for testing.

Data Collection Events

# Name Description Start End
0 CPSS_Antenatal - Cohort 2 - Retrospective survey 2019 (December) 2020 (December)

Individual Studies Included

Acronym Name Study design Participants Countries

Harmonization Projects Included

Acronym Name

Networks

Acronym Name Studies

Datasets

Name Type Data Collection Events Variables
Last Update: 2021-07-30 16:04